Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06665594 · ClinicalTrials.gov registry record · Phase 2
Effect of TXA on Reducing Bruising After Filler Injection
A Phase 2 study of Tranexamic Acid and Facial Filler Injections, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06665594 is a Phase 2 study of Tranexamic Acid and Facial Filler Injections that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 40 participants, below the 153-participant average among 3 other Tranexamic Acid trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06665594, a Phase 2 study of Tranexamic Acid and Facial Filler Injections, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to look at the effect tranexamic acid (TXA) may have on reducing bruising, swelling, and pain after facial filler injection. The main question it aims to answer is: * Does the addition of TXA to hyaluronic acid (HA) reduce bruising, swelling, and tenderness after HA injection? Participants will receive the study medication along with the standard facial filler injection and complete surveys.
Conditions Studied
Interventions
- PROCEDURE Hyaluronic Acid (HA)
- DRUG Tranexamic Acid (TXA)
- DRUG Saline (placebo)
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-12-05 |
| Est. Completion | 2026-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06665594
The ClinicalTrials.gov registry entry for NCT06665594 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 153-participant average among 3 other Tranexamic Acid trials with a reported enrollment target (74% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Tranexamic Acid appearing as the primary indexed condition, and to 3 interventions - of which Hyaluronic Acid (HA) is the first listed.
NCT06665594 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06665594 about?
NCT06665594 is a clinical study titled "Effect of TXA on Reducing Bruising After Filler Injection". The goal of this clinical trial is to look at the effect tranexamic acid (TXA) may have on reducing bruising, swelling, and pain after facial filler injection. The main question it aims to answer is: * Does the addition of TXA to hyaluronic acid (HA) reduce bruising, swelling, and tenderness after ...
What is the current status of trial NCT06665594?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2025-12-05. Estimated completion is 2026-11.
What conditions does trial NCT06665594 study?
This clinical trial studies the following conditions: Tranexamic Acid, Facial Filler Injections, Hyaluronic Acid.
What interventions are being tested in trial NCT06665594?
The interventions under investigation include: Hyaluronic Acid (HA) (PROCEDURE), Tranexamic Acid (TXA) (DRUG), Saline (placebo) (DRUG).
Who is sponsoring clinical trial NCT06665594?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06665594 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tranexamic Acid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
RECRUITING · Phase 2
-
The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery
COMPLETED · NA
-
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.